PT Darya-Varia Laboratoria Tbk (IDX:DVLA)

Indonesia · Delayed Price · Currency is IDR

1,580.00

+5.00 (0.32%)

Sep 22, 2026, 2:25 PM WIB

Market Cap	1.76T -3.1%
Revenue (ttm)	2.35T +12.8%
Net Income	136.23B -13.9%
EPS	121.63 -13.9%
Shares Out	1.12B
PE Ratio	12.95
Forward PE	n/a
Dividend	105.00 (6.65%)
Ex-Dividend Date	Jun 30, 2026

Volume	12,500
Open	1,580.00
Previous Close	1,575.00
Day's Range	1,575.00 - 1,585.00
52-Week Range	1,450.00 - 1,715.00
Beta	-0.09
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 27, 2026

About IDX:DVLA

PT Darya-Varia Laboratoria Tbk manufactures and trades pharmaceutical products and cosmetics in Indonesia. It operates in four segments: Consumer Health Products, Prescription Drugs, Export & Toll Manufacturing, and Services. The company offers consumer health products, including skin nutrition products under the Natur-E brand; respiratory products under the Decolgen, ALLERIN EXPECTORANT, Decolsin, NEOZEP, STOP COLD, SILEX, and HERBABLEND brands for nasal congestion, cough, and breathing issues caused by allergy; multivitamins under the Enervon... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1976

Employees 1,357

Stock Exchange Indonesia Stock Exchange

Ticker Symbol DVLA

Full Company Profile

Financial Performance

In 2025, IDX:DVLA's revenue was 2.23 trillion, an increase of 6.90% compared to the previous year's 2.09 trillion. Earnings were 163.95 billion, an increase of 5.00%.

Financial Statements